Basic Information
RNALocate ID: RLID:11004149
RNA Symbol: hsa-miR-885-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-885-3p
RNA ID: miRBase:MIMAT0004948
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 27278097
Tissue/Cell Line: Pooled sera
Method: miRNA array
Condition: Acute rejection (AR)|Bronchiolitis obliterans syndrome (BOS)|Stable
Description: Exosomes were defined by flow cytometry for CD63 and western blotting for annexin V SAgs, collagen V (Col-V) and Kα1 tubulin were examined by electron microscopy; miRNAs were profiled by a miRNA array. The global miRNA analysis demonstrated 123 detectable miRNAs (i.e., at least 1 pool with positive detection signal) in sera exosomes. Of these, 15 miRNAs were higher and 108 miRNAs were lower in AR LTxRs compared to stable LTxRs (Table S1). In contrast, 44 miRNAs were higher and 79 miRNAs were lower in BOS LTxRs compared to stable LTxRs (Table S1).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11004150 Exosome Plasma 23663360
RLID:11004151 Exosome Serum 24683445
RLID:11004152 Microvesicle Seminal plasma 23539611
RLID:11004153 Microvesicle Follicular fluid 23666971
RLID-D:11000724 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001601 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-885-3p Large cell neuroendocrine cancer MNDR-E-MI-70134
MNDR hsa-miR-885-3p Lymphoma MNDR-E-MI-70135
MNDR hsa-miR-885-3p Estrogen-receptor positive breast cancer MNDR-E-MI-70136
MNDR hsa-miR-885-3p Estrogen-receptor negative breast cancer MNDR-E-MI-70137
MNDR hsa-miR-885-3p Progesterone-receptor positive breast cancer MNDR-E-MI-70138
MNDR hsa-miR-885-3p Progesterone-receptor negative breast cancer MNDR-E-MI-70139
MNDR hsa-miR-885-3p Her2-receptor positive breast cancer MNDR-E-MI-70140
MNDR hsa-miR-885-3p Prostate cancer MNDR-E-MI-70141
MNDR hsa-miR-885-3p Hirschsprung disease MNDR-E-MI-70142
MNDR hsa-miR-885-3p Gastric cancer MNDR-E-MI-70143
MNDR hsa-miR-885-3p Alzheimer disease MNDR-E-MI-70144
MNDR hsa-miR-885-3p Prader-willi syndrome MNDR-E-MI-70145
MNDR hsa-miR-885-3p Leukemia MNDR-E-MI-70146
MNDR hsa-miR-885-3p Lung cancer MNDR-E-MI-70147
MNDR hsa-miR-885-3p Parkinson disease MNDR-E-MI-70148
MNDR hsa-miR-885-3p Breast cancer MNDR-E-MI-70149
MNDR hsa-miR-885-3p Pituitary neoplasms MNDR-E-MI-70150
MNDR hsa-miR-885-3p Malignant mesothelioma MNDR-E-MI-70151
MNDR hsa-miR-885-3p Pancreatic cancer MNDR-E-MI-70152
MNDR hsa-miR-885-3p Melanoma MNDR-E-MI-70153
MNDR hsa-miR-885-3p Nephroblastoma MNDR-E-MI-70154
MNDR hsa-miR-885-3p Relapsing-remitting multiple sclerosis MNDR-E-MI-70155
MNDR hsa-miR-885-3p Glioblastoma MNDR-E-MI-70156
MNDR hsa-miR-885-3p Chordoma MNDR-E-MI-70157
MNDR hsa-miR-885-3p Middle cerebral artery infarction MNDR-E-MI-70158
MNDR hsa-miR-885-3p Liver cancer MNDR-E-MI-70159
MNDR hsa-miR-885-3p Pituitary adenoma MNDR-E-MI-70160
MNDR hsa-miR-885-3p Kidney chromophobe MNDR-E-MI-70161
MNDR hsa-miR-885-3p Biliary tract cancer MNDR-E-MI-70162
MNDR hsa-miR-885-3p Cholangiocarcinoma MNDR-E-MI-70163
MNDR hsa-miR-885-3p Esophageal cancer MNDR-E-MI-70164
MNDR hsa-miR-885-3p Synovial sarcoma MNDR-E-MI-70165
MNDR hsa-miR-885-3p T acute lymphoblastic leukemia MNDR-E-MI-70166
MNDR hsa-miR-885-3p Acute t cell leukemia MNDR-E-MI-70167
MNDR hsa-miR-885-3p Progressive supranuclear palsy MNDR-E-MI-70168
MNDR hsa-miR-885-3p Malignant pleural mesothelioma MNDR-E-MI-70169
MNDR hsa-miR-885-3p Acute myelocytic leukemia MNDR-E-MI-70170
MNDR hsa-miR-885-3p Nasopharynx carcinoma MNDR-E-MI-70171
MNDR hsa-miR-885-3p Nasopharyngeal cancer MNDR-E-MI-70172
MNDR hsa-miR-885-3p Breast cancer her3+ negative MNDR-E-MI-70173
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter BMPR1A Homo sapiens RR00227442
TOP